A press release has been issued by Wave Life Sciences Ltd.
- Business
Announcement Date: October 16, 2024 (U.S. Time)
detail: A press release regarding the RestorAATion-2 clinical trial of WVE-006, targeting alpha-1 antitrypsin deficiency, has been issued by Wave, a key investment of our company. For more details, Here please refer to the original press release.